Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-14

Clinical Trial Update: Cortical Excitability Modulation With ctDCS in Fibromyalgia. [NA]

View source ↗

Summary

A clinical trial update reports on ctDCS-based cortical excitability modulation for fibromyalgia, sponsored by Hospital de Clinicas de Porto Alegre, currently a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Hospital de Clinicas de Porto Alegre | Conditions: Fibromyalgia, Chronic Pain | NA | Status: ACTIVE_NOT_RECRUITING